1. DEA Questions FDAs Reccomendation to Reschedule Cannabis Due To a Lack of Therapeutic Evidence SMH

    DEA Questions FDAs Reccomendation to Reschedule Cannabis Due To a Lack of Therapeutic Evidence SMH

    14